it s not just boilerplate
play

Its Not Just Boilerplate! Best practices for drafting collaboration - PowerPoint PPT Presentation

MARCH 13, 2013 Its Not Just Boilerplate! Best practices for drafting collaboration agreements to protect your IP By Elizabeth A. Howard, Ph.D. & Michael C. Spillner Presenters Elizabeth A. Howard, Ph.D. Michael C. Spillner Orrick


  1. MARCH 13, 2013 It’s Not Just Boilerplate! Best practices for drafting collaboration agreements to protect your IP By Elizabeth A. Howard, Ph.D. & Michael C. Spillner

  2. Presenters Elizabeth A. Howard, Ph.D. Michael C. Spillner • Orrick IP partner • Orrick IP partner • J.D., Hastings College of the Law • J.D., Stanford Law School • Ph.D., U.C. Berkeley, Molecular Biology • B.A., UCLA 2

  3. Outline • 1. The collaboration conundrum • 2. The Tekmira case: a cautionary tale • 3. Best practices for drafting specific provisions 3

  4. Outline • 1. The collaboration conundrum • 2. The Tekmira case: a cautionary tale • 3. Best practices for drafting specific provisions 4

  5. The collaboration conundrum • Collaborations are for the parties ’ mutual benefit, Collaborations are for the parties ’ mutual benefit, • but their interests are never fully aligned. 5

  6. The collaboration conundrum • A collaborator today can be a competitor tomorrow. • A collaborator today can be a competitor tomorrow. 6

  7. The risk 18 16 14 12 10 8 6 4 2 MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL 2 0 1 3 2 0 1 3 2 0 1 4 2 0 1 4 2 0 1 5 2 0 1 5 7

  8. The risk 18 16 14 12 10 8 6 4 2 MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL 2 0 1 3 2 0 1 3 2 0 1 4 2 0 1 4 2 0 1 5 2 0 1 5 8

  9. Strategies to deal with the conundrum • rock the boat • achieve clarity • limit access • don ’ t share what you can ’ t afford to lose 9

  10. Outline • 1. The collaboration conundrum • 2. The Tekmira case: a cautionary tale • 3. Best practices for drafting specific provisions 10

  11. The Tekmira case: a cautionary tale • drug development collaboration • collaborators became competitors • lawsuit over IP ownership 11

  12. Outline • 1. The collaboration conundrum • 2. The Tekmira case: a cautionary tale • 3. Best practices for drafting specific provisions 12

  13. Best practices for specific provisions • confidentiality clauses • IP clauses • license and sublicense rights • 13

  14. Best practices for specific provisions • confidentiality clauses • IP clauses • license and sublicense rights • 14

  15. Confidentiality clauses 15

  16. Confidentiality clauses: non-use 16

  17. Confidentiality clauses: non-disclosure 17

  18. Confidentiality clauses: exceptions • Exceptions – they can swallow the rule. • 18

  19. Standard exceptions • known by receiving party prior to effective date • lawfully disclosed to receiving party by another • the information becomes published through no fault of • the information becomes published through no fault of the receiving party • independently developed by receiving party without reference to the confidential information • 19

  20. Non-standard exceptions information can be disclosed if “ reasonably necessary ” to information can be disclosed if “ reasonably necessary ” to conduct clinical trials or obtain regulatory approval 20

  21. Non-standard exceptions information can be disclosed if “ reasonably necessary ” for information can be disclosed if “ reasonably necessary ” for the prosecution or maintenance of patent rights 21

  22. Non-standard exceptions information can be disclosed if “ reasonably required ” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality 22

  23. Non-standard exceptions information can be disclosed if “ reasonably required ” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality 23

  24. Non-standard exceptions information can be disclosed if “ reasonably required ” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality  or: “You must keep my information confidential . . . . unless you can sell it.” 24

  25. Non-standard exceptions information can be disclosed if “ reasonably required ” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality 25

  26. Non-standard exceptions information can be disclosed if “ reasonably required ” to information can be disclosed if “ reasonably required ” to comply with applicable laws or regulations or legal process 26

  27. Notice and consent 27

  28. Limitations on disclosures 28

  29. Advanced confidentiality protection • limit disclosure to specific persons named in advance in writing • limit disclosure to specific purpose • require employees to personally execute NDA • require employees to personally execute NDA • require encryption and passwords for electronic files • require maintenance of access log and audit rights • prohibit any disclosure to third parties • always require advance notice & written consent 29

  30. Best practices for specific provisions • confidentiality clauses • IP clauses • license and sublicense rights • 30

  31. IP Clauses • example provision 31

  32. Preexisting IP • ownership – keep with original owner • how to define • right to use / license / sublicense 32

  33. Improvements / derivatives when one party uses the information it learns from the collaboration as a starting point for new inventions 33

  34. Patent thicket Your Your Your Your IP IP IP IP 34

  35. Patent thicket Your Your Your Your IP IP IP IP 35

  36. Improvements / derivatives • threshold issue of whether to allow improvements • if you decide to allow improvements  specify purposes for which improvements can be made  specify purposes for which improvements can be made  address ownership  address ability to use, license, sublicense improvements 36

  37. Collaboration IP • defining collaboration IP  consider periodic updates to ensure parties are on same page  consider streamlined arbitration process to resolve disputes  consider streamlined arbitration process to resolve disputes • ownership of collaboration IP • rights to use, license, sublicense collaboration IP 37

  38. Right to patent 38 p 35 p 35

  39. Right to patent • preexisting IP • improvements • collaboration IP • notice & consent 39

  40. Best practices for specific provisions • confidentiality clauses • IP clauses • license and sublicense rights • 40

  41. Ownership vs. licensing Ownership Ownership License License 41

  42. License grant clarify what is being licensed • patents • know-how • know-how • other rights • other information 42

  43. License grant clarify scope of license • right to use, commercialize, manufacture, etc. • for any purpose, or only purpose of collaboration? • for any purpose, or only purpose of collaboration? • for any use? • for whose benefit? 43

  44. Sublicense rights decide whether to allow sublicense rights or not • you may lose control over your IP • you may not be getting an appropriate benefit • you may lose business opportunities 44

  45. Sublicense rights if you decide to grant sublicense rights • • get the appropriate benefit of any sublicense get the appropriate benefit of any sublicense • protect your information 45

  46. Best practices • rock the boat • clarity and transparency • limit access of what is shared • don ’ t share what you can ’ t afford to lose 46

  47. Thank you • For copies of this presentation • and MCLE forms, please visit: • http://www.orrick.com/Events-and- Publications/Pages/It-Is-Not-Just-Boilerplate.aspx 47

  48. Thank you Elizabeth A. Howard, Ph.D. Michael C. Spillner ehoward@orrick.com mspillner@orrick.com (650) 614-7316 (650) 614-7395 48

Recommend


More recommend